161 related articles for article (PubMed ID: 15173025)
1. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Sundström J; Evans JC; Benjamin EJ; Levy D; Larson MG; Sawyer DB; Siwik DA; Colucci WS; Sutherland P; Wilson PW; Vasan RS
Circulation; 2004 Jun; 109(23):2850-6. PubMed ID: 15173025
[TBL] [Abstract][Full Text] [Related]
2. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
Hansson J; Lind L; Hulthe J; Sundström J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
[TBL] [Abstract][Full Text] [Related]
3. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study.
Sundström J; Evans JC; Benjamin EJ; Levy D; Larson MG; Sawyer DB; Siwik DA; Colucci WS; Wilson PW; Vasan RS
Eur Heart J; 2004 Sep; 25(17):1509-16. PubMed ID: 15342170
[TBL] [Abstract][Full Text] [Related]
4. Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study.
Vasan RS; Evans JC; Benjamin EJ; Levy D; Larson MG; Sundstrom J; Murabito JM; Sam F; Colucci WS; Wilson PW
Hypertension; 2004 May; 43(5):957-62. PubMed ID: 15007028
[TBL] [Abstract][Full Text] [Related]
5. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
6. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
[TBL] [Abstract][Full Text] [Related]
7. Association of left ventricular dilatation and hypertrophy with chronotropic incompetence in the Framingham Heart Study.
Lauer MS; Larson MG; Evans JC; Levy D
Am Heart J; 1999 May; 137(5):903-9. PubMed ID: 10220640
[TBL] [Abstract][Full Text] [Related]
8. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
9. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.
Kitaoka H; Kubo T; Okawa M; Takenaka N; Baba Y; Yamasaki N; Matsumura Y; Furuno T; Doi YL
J Cardiol; 2011 Nov; 58(3):261-5. PubMed ID: 21890325
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study.
Tsao CW; Gona PN; Salton CJ; Chuang ML; Levy D; Manning WJ; O'Donnell CJ
J Am Heart Assoc; 2015 Sep; 4(9):e002188. PubMed ID: 26374295
[TBL] [Abstract][Full Text] [Related]
11. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.
Wang TJ; Larson MG; Benjamin EJ; Siwik DA; Safa R; Guo CY; Corey D; Sundstrom J; Sawyer DB; Colucci WS; Vasan RS
Am Heart J; 2007 Aug; 154(2):291-7. PubMed ID: 17643579
[TBL] [Abstract][Full Text] [Related]
12. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study.
Dhingra R; Pencina MJ; Benjamin EJ; Levy D; Larson MG; Meigs JB; Rifai N; D'Agostino RB; Vasan RS
Am J Hypertens; 2004 Oct; 17(10):891-6. PubMed ID: 15485750
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study.
Dhingra R; Ho Nam B; Benjamin EJ; Wang TJ; Larson MG; D'Agostino RB; Levy D; Vasan RS
J Am Coll Cardiol; 2005 Mar; 45(5):685-9. PubMed ID: 15734611
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function and left ventricular structure and function in the Framingham Heart Study.
Pearce EN; Yang Q; Benjamin EJ; Aragam J; Vasan RS
Thyroid; 2010 Apr; 20(4):369-73. PubMed ID: 20210671
[TBL] [Abstract][Full Text] [Related]
17. Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women.
Peter I; Shearman AM; Vasan RS; Zucker DR; Schmid CH; Demissie S; Cupples LA; Kuvin JT; Karas RH; Mendelsohn ME; Housman DE; Benjamin EJ
Am J Hypertens; 2005 Nov; 18(11):1388-95. PubMed ID: 16280269
[TBL] [Abstract][Full Text] [Related]
18. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of aortic root dimension in persons > or = 65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study).
Gardin JM; Arnold AM; Polak J; Jackson S; Smith V; Gottdiener J
Am J Cardiol; 2006 Jan; 97(2):270-5. PubMed ID: 16442377
[TBL] [Abstract][Full Text] [Related]
20. Change in left ventricular geometry over 10 years in the elderly and risk of incident cardiovascular disease.
Lind L; Sundström J
J Hypertens; 2019 Feb; 37(2):325-330. PubMed ID: 30113528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
